Please use this identifier to cite or link to this item: https://dspace.ncfu.ru/handle/123456789/34345
Title: Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment
Authors: Rzhepakovsky, I. V.
Ржепаковский, И. В.
Povetkin, S. N.
Поветкин, С. Н.
Keywords: Agonist;PPARŒ±;Cancer treatment;Modulators;PPAR;Antagonist;Animals;Antineoplastic agents
Issue Date: 2026
Publisher: Bentham Science Publishers
Citation: Kaveriyappan Govindarajan R., Prathiviraj R., Qasim Waheeb M., Al-Duais M.A., Asmari A., Panneerselvam C., Rzhepakovsky I., Povetkin S., Dahms H.-U. The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment // Current Cancer Drug Targets. - 2026. - 26 (6). - pp. 633 - 648. - DOI: 10.2174/0115680096423510251031065737
Series/Report no.: Current Cancer Drug Targets
Abstract: Cancer is one of the leading causes of mortality globally. PPAR modulators may hold great potential for the management of cancer patients. PPAR modulators also activate specific transcriptional pathways, regulate immune responses and inflammation, and influence the proliferation of various cancer cell types. In the last decade, emerging evidence has shown that PPARŒ±, a nuclear hormone receptor, can modulate carcinogenesis via exerting effects on one or several characteristic pathological behaviors of cancer. This review summarizes current knowledge of PPARŒ± function in various aspects of cancer development and the modulators that regulate PPARŒ±. Based on the current knowledge, we have discussed the development of a potential modulator targeting PPARŒ± for cancer treatment.
URI: https://dspace.ncfu.ru/handle/123456789/34345
Appears in Collections:Статьи, проиндексированные в SCOPUS, WOS

Files in This Item:
File Description SizeFormat 
scopusresults 4148.pdf
  Restricted Access
126.26 kBAdobe PDFView/Open
WoS 2428.pdf
  Restricted Access
118.53 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.